-The New Indian Express NAGAPATTINAM: Ever tried traditional rice, the one that looks brownish-red? It may taste a bit different but it has immense health benefits. In fact, the biggest consumers of traditional rice breeds are private super specialty hospitals across major cities, which cater to dietary needs of patients, predominantly diabetics. Besides health benefits, the breeds - Maapillai Samba, Kavuni, Garudan Samba, Thanga Samba and Samba Mosanam - are said to...

-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...

-The Telegraph New Delhi: A government agency has blocked its own pledge to impose price control on more medicines by withdrawing guidelines that it had used in July this year to cap prices of drugs used to treat diabetes and cardiovascular diseases. The National Pharmaceutical Pricing Authority (NPPA) has withdrawn the guidelines issued under Paragraph 19 of the Drug Price Control Order that it had used in July this year to cap...

-The Business Standard WTO reconvenes to re-examine issue of agriculture subsidies, numbers alone suggest that India has a strong case for declining to sign WTO's TFA The World Trade Organisation (WTO) is reconvening in the last week of September to examine the issue of agricultural subsidies against the backdrop of India's refusal to become a signatory to the trade facilitation agreement (TFA) at Bali. Since then, a lot of water has flowed...

-The Hindu Business Line Fate of 108 drugs brought under price control in July still unclear In a booster for pharmaceutical companies, the Government has ensured that the National Pharmaceutical Pricing Authority (NPPA) no longer enjoys sweeping powers to control drug prices. The NPPA on Tuesday withdrew the guidelines it issued on May 29 that allowed the Authority to control drug prices in public interest. Based on this, it had subsequently capped prices...